Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.

Mol Clin Oncol · 2025 · PMC12035524 · PMID 40297501

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The study conducted by Abali et al ( 7 ) in 2015 as a Turkish Oncology Group project, which analysed data from 1,157 Turkish patients with cutaneous melanoma, was highly significant and pioneering in this field in Turkey.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.